menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Imfinzi Shows EFS Benefit In Early Gastric, GEJ Cancers

    BUSINESSWIRE

    Pfizer angles Braftovi combo for full FDA approval

    PRESS RELEASE

    Kindos`s Generics Fluorouracil Receives Approval in US

    FDA

    Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

    PRESS RELEASE

    Encube Ethicals` Generic Fluorouracil Receives Approval in the U.S.

    FDA

    Alembic`s Generic Fluorouracil Receives Approval in the U.S.

    FDA

    FOLFOX Produces Varying Toxicity Profile vs Chemoradiation in Rectal Cancer

    ONCLIVE

    Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 Ml

    EXPRESS PHARMA

    Enforcement Report - Week of February 1, 2023

    FDA

    Merck Provides Update on Phase 3 KEYNOTE-921

    BUSINESSWIRE

    Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde

    BUSINESSWIRE

    Accord Hlthcare`s Generic Fluorouracil Receives Approval In US

    FDA

    Merck receives European approval for Keytruda in combo with chemotherapy

    PHARMABIZ

    Amgen Announced Updated results from the Phase 2 FIGHT trial

    PRNEWSWIRE

    EMA recommendations on DPD testing prior to treatment with fluorouracil

    EMA

    Ingenus Pharms`s Generic Fluorouracil Receives Approval in US

    FDA

    Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA®

    BIOSPACE

    Enforcement Report - Week of July 24, 2019

    FDA

    Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection Due to the Potential for Glass Particulate

    FDA

    EMA Begins Review of Screening Patients Before Fluorouracil

    RAPS

    EMA Approved 5 fluorouracil List of nationally authorised medicinal products

    EMA

    DFB Soria Completes a Ph2 Trial of Submicron Particle Paclitaxel Anhy for AK

    BUSINESSWIRE

    Merck claims a win for Keytruda with interim OS data in H&NC

    ENDPTS

    China slashes value added tax on over 100 cancer drugs

    PLATFORM

    Gland Pharma’s Generic Fluorouracil Receives Approval In US

    FDA

    Enforcement Report - Week of March 22, 2017

    FDA

    Tocagen begins enrolling patients in Toca 5 phase 2/3 trial in South Korea

    PHARMABIZ

    NICE Rejects Shire’s Pancreatic Cancer Drug

    PHARMATIMES

    Merrimack, Baxalta Announce Initiation of Phase 1 Study of MM-151 with ONIVYDE

    PR NEWSWIRE

    PharmaEngine Announces Korean Ministry of Food and Drug Safety Accepted ONIVYDE

    PR NEWSWIRE

    High Ester Pectin Based Formulation for Site Specific Delivery of 5-Fluorouracil in to Descending Colon

    PHARMA-EXCIPIENTS

    Sagent Pharm`s Generic Fluorouracil approved in US for treatment of cancer

    FDA

    Updated Data Shows ONIVYDE® Combination Regimen Increased One Year Survival

    PR NEWS WIRE

    Merrimack to Present Overall Survival Analysis of Ph3 NAPOLI-1 Study of ONIVYDE

    PR NEWS WIRE

    Hill Dermac`s Tolak (Fluorouracil) approved in US for Skin Cancer

    Teva recalls Adrucil (fluorouracil injection) 5 g/100 mL due to Presence of Particulate Matter

    FDA

    Teva Parenteral Medicines Recalls Lots of Adrucil® (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter

    FDA LAW BLOG

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Lilly`s CYRAMZA® (Ramucirumab) Receives Supplemental Approval in USA for Cancer

    LILLY

    Colorectal Cancer: What You Should Know

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.